All patients (n = 311) | 2020 (n = 111) | 2019 (n = 200) |
P
|
|
Age (yrs) | 66 + 11 | 67 + 10 | 66 + 12 | 0.4 |
Male (%) | 205 (66) | 77 (69) | 128 (64) | 0.6 |
BMI (Kg/m2) | 29 + 6 | 29 + 6 | 29 + 6 | 1 |
Creatinine (mg/dL) | 1.0 + 0.3 | 1.0 + 0.3 | 1.0 + 0.3 | 0.2 |
LA diameter (cm) | 4.3 + 0.7 | 4.0 + 0.7 | 4.3 + 0.7 | 0.3 |
Ejection Fraction (%) | 58 (10) | 58 (12) | 58 (9) | 0.7 |
CHA2DS2-VASc | 2.4 + 1.7 | 2.0 + 1.6 | 2.4 + 1.7 | 0.8 |
Hypertension (%) | 188 (61) | 71 (64) | 117 (59) | 0.5 |
Diabetes (%) | 45 (15) | 12 (11) | 33 (16) | 0.2 |
Coronary Disease (%) | 57 (18) | 20 (18) | 37 (18) | 0.9 |
Stroke or TIA (%) | 27 (9) | 15 (14) | 12 (6) | 0.03 |
Heart Failure (%) | 48 (15) | 16 (14) | 32 (16) | 0.7 |
Persistent AF (%) | 121 (39) | 56 (50) | 65 (32) | <0.01 |